4.7 Review

Nanomedicine as a potential approach to empower the new strategies for the treatment of preeclampsia

期刊

DRUG DISCOVERY TODAY
卷 23, 期 5, 页码 1099-1107

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2018.01.048

关键词

-

资金

  1. Institut National de la Sante et de la Recherche Medicale (INSERM)
  2. Centre National de la Recherche Scientifique (CNRS)
  3. French ministry of research

向作者/读者索取更多资源

Preeclampsia is a serious pregnancy disorder characterized by the onset of high blood pressure and proteinuria. Although the understanding of the disease is increasing, it remains without treatment, other than the delivery of the baby and the placenta. This review sets out to discuss some new developments and strategies in the treatment of preeclampsia. We briefly review the current knowledge on the preeclamptic pathophysiology. We then examine the recent trends in preeclampsia treatment and, in particular, the tracks of potential therapeutic targets. Finally, we focus on the possibilities nanocarriers could offer in the management of preeclampsia. Indeed, nanocarriers could help to prevent transplacental passage and promote placental-specific drug delivery, thereby enhancing efficacy and improving safety. Tendencies are then drawn from the available studies on the optimal characteristics of a nanocarrier to deliver drugs to the placenta.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据